Work

Phase 1 Trial Of Carfilzomib + High Dose Melphalan Conditioning Regimen Prior To Autologous Hematopoietic Stem Cell Transplantation (AHSCT) For Relapsed Multiple Myeloma

Year: 2013

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v122.21.3329.3329

Authors: Luciano J Costa, Heather Landau, Jagadish K Venkata, Yubin Kang, Guenther Koehne, David J Chung, Nikoletta Lendvai, Tricia Bentz, Sergio Giralt

Institutions: Medical University of South Carolina, Memorial Sloan Kettering Cancer Center, MUSC Hollings Cancer Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2216597617

FWCI:

Cites:

Cited by: 1

Related to: 10